Genetic Profiles May Improve Diagnostic Accuracy in Parkinsonian Disorders
A large-scale study of brain bank data reveals that clinical misdiagnosis of Parkinsonian disorders remains common, ranging from 10% to 20%. Researchers suggest that integrating genetic and pathological data can significantly improve diagnostic accuracy for conditions like Parkinson's disease and dementia.
Why it matters
Improving diagnostic accuracy is critical for ensuring patients receive appropriate treatments and for advancing research into neurodegenerative diseases.
Clinical diagnoses of Parkinsonian disorders generally reflect underlying neuropathology, but misdiagnosis remains common and underlying pathology differs by genetic variants and ancestry, according to study findings published in JAMA Neurology .
To determine how accurately clinical diagnoses of Parkinsonian disorders reflect underlying neuropathology, and whether pathology differs by genetic variants and ancestry, researchers conducted a retrospective, multicenter cross-sectional study using data from 11 academic brain banks in the UK, US, and Australia. The analysis incorporated clinical, neuropathological, and genetic information from brain donors enrolled between 1985 and 2024.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in